Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma

Fig. 2

Relationship between the expression of CASC7 and tumor number, IM, tumor size, and TNM stage, and its diagnostic value. (a) Relationship between CASC7 expression and tumor number. (b) Relationship between CASC7 expression and IM. (c) Relationship between CASC7 expression and tumor size. (d) Relationship between CASC7 expression and TNM stage. (e) ROC curves of CASC7 and AFP for differential diagnosis of multiple tumors from solitary tumors. (f) ROC curves of CASC7 and AFP for differential diagnosis of IM-positive from IM-negative. (g) ROC curves of CASC7 and AFP for differential diagnosis of tumor size ≥ 5 from < 5. (h) ROC curves of CASC7 and AFP for differential diagnosis of TNM III + IV from TNM I + II. *p < 0.05, **p < 0.01, ***p < 0.001. CASC7: cancer susceptibility candidate 7, IM: intrahepatic metastasis, TNM: tumor node metastasis, ROC: receiver operating characteristic, AFP: alpha fetoprotein

Back to article page